Clinical Trial Update: Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selegiline patch for cognitive impairment in HIV patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognition Disorders
• HIV Infections

Drugs mentioned

• Selegiline patch (selegiline)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Cognition Disorders, HIV Infections | Phase 2 | Status: COMPLETED